Amico Laboratories Ltd. operates under the full authority and oversight of the Directorate General of Drug Administration (DGDA), Government of the People's Republic of Bangladesh. We maintain the highest standards of pharmaceutical manufacturing, quality control, and drug safety as prescribed by the Drug Act 1940 and Drug Rules 1946.
Every product in our portfolio undergoes rigorous registration, testing, and post-market surveillance processes to ensure public safety and therapeutic efficacy.
Valid DGDA manufacturing license for pharmaceutical dosage forms including tablets, capsules, syrups, and injectables.
Our manufacturing facility adheres to WHO Good Manufacturing Practice guidelines with regular DGDA inspections.
All 200+ products registered with DGDA with complete bioequivalence and stability study documentation.
Active adverse drug reaction monitoring and reporting system in accordance with DGDA requirements.